Formulation of Ceftriaxone Sodium Under the Guidance of Drug Quality Analysis
Crossref DOI link: https://doi.org/10.1007/s11094-023-02823-2
Published Online: 2023-02-28
Published Print: 2023-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chong, Xiaomeng
Wang, Lixin
Hu, Changqin
He, Langchong
Text and Data Mining valid from 2023-02-01
Version of Record valid from 2023-02-01
Article History
Received: 13 January 2022
First Online: 28 February 2023
CONFLICT OF INTEREST
: The authors declare that they have no conflicts of interest.